SBC Medical Group Holdings Incorporated Provision for Other Credit Losses
SBC Medical Group Holdings Incorporated (SBC) reported Provision for Other Credit Losses of -$44.75 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProvisionForOtherCreditLosses · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated provision for other credit losses for the quarter ending 2026-06-30 was -$13.40K, a 105.18% decline year-over-year.
- SBC Medical Group Holdings Incorporated provision for other credit losses for the quarter ending 2026-03-31 was -$31.35K, a 224.90% decline year-over-year.
- SBC Medical Group Holdings Incorporated provision for other credit losses for the quarter ending 2025-12-31 was -$3.01K.
- SBC Medical Group Holdings Incorporated provision for other credit losses for the quarter ending 2025-09-30 was $22.21K.
- SBC Medical Group Holdings Incorporated provision for other credit losses for fiscal 2025 was $302.95K.
- SBC Medical Group Holdings Incorporated provision for other credit losses for fiscal 2024 was -$402.20K, a 208.48% decline from fiscal 2023.
- SBC Medical Group Holdings Incorporated provision for other credit losses for fiscal 2023 was $370.75K.
| Period end | Provision for Other Credit Losses 3 month | Provision for Other Credit Losses 6 month | Provision for Other Credit Losses 9 month | Provision for Other Credit Losses 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$13.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$44.75K 10-Q · filed 2026-08-13 | -$47.77K derived: sum of 3 quarters · filed 2026-08-13 | -$25.56K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$31.35K 10-Q · filed 2026-05-14 | -$34.37K derived: sum of 2 quarters · filed 2026-05-14 | -$12.16K derived: sum of 3 quarters · filed 2026-05-14 | $246.49K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$3.01K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $19.20K derived: sum of 2 quarters · filed 2026-03-27 | $277.85K derived: sum of 3 quarters · filed 2026-08-13 | $302.95K 10-K · filed 2026-03-27 |
| 2025-09-30 | $22.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $280.86K derived: sum of 2 quarters · filed 2026-08-13 | $305.96K 10-Q · filed 2025-11-14 | $30.96K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $258.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $283.75K 10-Q · filed 2026-08-13 | $8.75K derived: sum of 3 quarters · filed 2026-08-13 | -$181.25K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $25.10K 10-Q · filed 2026-05-14 | -$249.90K derived: sum of 2 quarters · filed 2026-05-14 | -$439.90K derived: sum of 3 quarters · filed 2026-05-14 | -$529.67K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$275.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$465.00K derived: sum of 2 quarters · filed 2026-03-27 | -$554.77K derived: sum of 3 quarters · filed 2026-03-27 | -$402.20K 10-K · filed 2026-03-27 |
| 2024-09-30 | -$190.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$279.77K derived: sum of 2 quarters · filed 2025-11-14 | -$127.20K 10-Q · filed 2025-11-14 | -$39.38K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$89.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $62.80K 10-Q · filed 2025-08-13 | $150.62K derived: sum of 3 quarters · filed 2025-08-13 | |
| 2024-03-31 | $152.58K 10-Q · filed 2025-05-15 | $240.40K derived: sum of 2 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $87.82K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $370.75K 10-K · filed 2025-03-28 | ||
| 2023-09-30 | $282.93K 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |